<DOC>
	<DOCNO>NCT00236431</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety galantamine treatment patient mild cognitive impairment .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety Galantamine Patients With Mild Cognitive Impairment</brief_title>
	<detailed_description>This international , multicenter , double-blind , randomize , placebo-controlled trial . Patients mild cognitive impairment ( MCI ) clinically risk development Alzheimer 's disease treat 24 month either placebo galantamine hydrobromide . Memory overall clinical improvement evaluate use Alzheimer 's Disease Assessment Scale cognitive subscale adapt MCI ( ADAS-cog/MCI ) Clinical Dementia Rating Sum Boxes ( CDR-SB ) . Overall functional skill severity dementia assess Clinical Dementia Rating Sum Boxes ( CDR-SB ) overall Clinical Dementia Rating ( CDR ) score . Additional assessment include Digit Symbol Substitution Test ( DSST ) measure attention . Safety assess use adverse event report , vital sign , laboratory parameter , physical examination , electrocardiogram . The study hypothesis treatment galantamine well tolerate , compare placebo , significantly improve sign symptom associate mild cognitive impairment patient consider likely develop Alzheimer 's disease . Galantamine hydrobromide immediate-release tablet ( 4 , 8 , 12 milligram ) , take mouth 2 time daily : 8mg/day 4 week , 16mg/day 4 week , increase 24mg/day remainder 24-month trial . Doses may reduce investigator 's discretion 12 week .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Galantamine</mesh_term>
	<criteria>Clinical decline cognitive ability consistent mild cognitive impairment Delayed recall score &lt; = 10 New York University paragraph recall test Sufficient visual , hear communication capability willing complete serial standard test cognitive function Have consistent informant accompany schedule visit Be able read , write fully understand language cognitive scale use study Neurodegenerative disorder Parkinson 's disease Cognitive impairment result acute cerebral trauma , hypoxic cerebral damage , vitamin deficiency state , infection meningitis AIDS , primary metastatic cerebral neoplasia Epilepsy Significant psychiatric disease Peptic ulcer disease Clinically significant heart , lung , liver kidney diseases Pregnant nursing woman without adequate contraception</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Mild cognitive impairment</keyword>
	<keyword>Galantamine hydrobromide</keyword>
	<keyword>Memory disorder</keyword>
</DOC>